US · Healthcare

HCW Biologics Inc (HCWB)

Biotechnology

HCW Biologics Inc (HCWB) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for HCWB

P/E ratio

25.00

HCW Biologics Inc (HCWB) — FAQ

What is HCWB's P/E ratio?

The price-to-earnings (P/E) ratio for HCW Biologics Inc (HCWB) is 25.00 (data as of 2026-05-23).

Does HCW Biologics Inc pay a dividend?

Dividend yield is not available in the current snapshot for HCW Biologics Inc (HCWB). Check the MyAverix Finance app for the latest dividend data.

What sector is HCW Biologics Inc in?

HCW Biologics Inc (HCWB) is classified in the Healthcare sector (Biotechnology industry).

What exchange is HCWB listed on?

HCWB is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)